Literature DB >> 15757804

Histopathology of liver cancers.

Masamichi Kojiro1.   

Abstract

Recently, new pathomorphologic information about early-stage small hepatocellular carcinoma (HCC) and the multi-step process of human hepatocarcinogenesis has been obtained, along with advances in the development of diagnostic modalities. The most valuable information is that in the majority of cases HCC arises as a very well differentiated cancer and proliferates with a stepwise process of dedifferentiation. In addition, it has been suggested that many HCCs seem to arise from dysplastic nodules (DNs) on the basis of the following evidence: the presence of DNs containing HCC foci, frequent association of DNs in the vicinity of HCC, and clinical progression from DN to HCC. However, as many HCCs are still detected at an advanced stage, it is also important to understand not only the classical pathologic features of HCC but also unusual features such as scirrhous change, sarcomatous change, fibrolamellar variant, and intra-bile duct or intra-atrial tumor growth.

Entities:  

Mesh:

Year:  2005        PMID: 15757804     DOI: 10.1016/j.bpg.2004.10.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  33 in total

Review 1.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

2.  Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling.

Authors:  Tong San Koh; Choon Hua Thng; Septian Hartono; Puor Sherng Lee; Su Pin Choo; Donald Y H Poon; Han Chong Toh; Sotirios Bisdas
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

Review 3.  Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?

Authors:  Yang Shin Park; Chang Hee Lee; Jeong Woo Kim; Sora Shin; Cheol Min Park
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

Review 5.  Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

6.  Establishment of cancer cell lines from rat hepatocholangiocarcinoma and assessment of the role of granulocyte-colony stimulating factor and hepatocyte growth factor in their growth, motility and survival.

Authors:  Anna C Piscaglia; Thomas D Shupe; Giovanbattista Pani; Valentina Tesori; Antonio Gasbarrini; Bryon E Petersen
Journal:  J Hepatol       Date:  2009-04-05       Impact factor: 25.083

7.  Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6.

Authors:  Hongcheng Sun; Huamei Tang; Dacheng Xie; Zhiliang Jia; Zhenyu Ma; Daoyan Wei; Lopa Mishra; Yong Gao; Shaojiang Zheng; Keping Xie; Zhihai Peng
Journal:  Clin Cancer Res       Date:  2015-09-02       Impact factor: 12.531

8.  Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.

Authors:  Kui Wang; Forrest M Kievit; Jonathan G Sham; Mike Jeon; Zachary R Stephen; Arvind Bakthavatsalam; James O Park; Miqin Zhang
Journal:  Small       Date:  2015-12-07       Impact factor: 13.281

Review 9.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

10.  Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.

Authors:  Haluk Yuzugullu; Khemais Benhaj; Nuri Ozturk; Serif Senturk; Emine Celik; Asli Toylu; Nilgun Tasdemir; Mustafa Yilmaz; Esra Erdal; Kamil Can Akcali; Nese Atabey; Mehmet Ozturk
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.